Skip to main content
Top
Published in: Abdominal Radiology 1/2006

01-02-2006 | UPDATE

Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT

Authors: M. Kanematsu, S. Osada, N. Amaoka, S. Goshima, H. Kondo, N. Moriyama

Published in: Abdominal Radiology | Issue 1/2006

Login to get access

Abstract

We summarize and discuss our previous research results on the correlation between findings on magnetic resonance (MR) imaging and angiographically assisted computed tomography (CT) and the intensity of vascular endothelial growth factor (VEGF) expression in hepatocellular carcinoma (HCC) and in the surrounding nontumorous liver. MR images (n = 22), CT during arterial portography (n = 20), and CT hepatic arteriography (n = 17) were retrospectively correlated quantitatively and qualitatively with VEGF expression in HCCs and in the surrounding liver assessed by western blotting. HCC-to-liver contrast-to-noise ratio correlated with VEGF expression index (VEGFIND) values of HCCs inversely on opposed-phase, T1-weighted, spoiled gradient recalled-echo (GRE) images, directly on T2-weighted, fast spin-echo images, and marginally and inversely on gadolinium-enhanced hepatic arterial-phase GRE images. On T2-weighted fast spin-echo images, standard deviation ratio of HCCs correlated directly with VEGFIND values of HCCs. By CT hepatic arteriography, the contrast-enhancement index of HCCs showed a moderate inverse correlation with VEGFIND values of HCCs, and the contrast-enhancement index of the liver showed marginal, moderate direct correlation with VEGFIND values in the liver. Heterogeneities of HCCs on images correlated directly with VEGFIND values of HCCs on opposed-phase T1-weighted GRE images, T2-weighted fast spin-echo images, hepatic arterial-phase GRE images, equilibrium-phase GRE images, and CT hepatic arteriogram. Our results may reflect that MR signal intensity, hepatic arterial vascularity, and heterogeneity of HCCs on CT or MR images are closely related to the intensity of VEGF expression in HCC as upregulated by hyper- or hypoxia in HCCs. Although the real effects of our results on radiologic practice are debatable at this moment, we believe that our results may help future radiologic practice in conjunction with biomolecular or genetic treatment for HCCs.
Literature
1.
2.
go back to reference Ferrara N (1999) Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237:1–30PubMed Ferrara N (1999) Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 237:1–30PubMed
3.
go back to reference Houck KA, Leung DW, Rowland AM, et al. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031–26037PubMed Houck KA, Leung DW, Rowland AM, et al. (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 267:26031–26037PubMed
4.
go back to reference Yamane A, Seetharam L, Yamaguchi S, et al. (1994) A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9:2683–2690PubMed Yamane A, Seetharam L, Yamaguchi S, et al. (1994) A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene 9:2683–2690PubMed
5.
go back to reference Mise M, Arii S, Higashituji H, et al. (1996) Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumors. Hepatology 23:455–464PubMed Mise M, Arii S, Higashituji H, et al. (1996) Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumors. Hepatology 23:455–464PubMed
6.
go back to reference Yamaguchi R, Yano H, Iemura A, et al. (1998) Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 28:68–77PubMed Yamaguchi R, Yano H, Iemura A, et al. (1998) Expression of vascular endothelial growth factor in human hepatocellular carcinoma. Hepatology 28:68–77PubMed
7.
go back to reference Ohmori S, Shiraki K, Sugimoto K, et al. (2001) High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol 32:1363–1370PubMedCrossRef Ohmori S, Shiraki K, Sugimoto K, et al. (2001) High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. Hum Pathol 32:1363–1370PubMedCrossRef
8.
go back to reference Monacci WT, Merril MJ, Oldfield EH (1993) Expression of vascular permeability factor/vascular endothelial factor in normal rat tissues. Am J Physiol 264:995–1002 Monacci WT, Merril MJ, Oldfield EH (1993) Expression of vascular permeability factor/vascular endothelial factor in normal rat tissues. Am J Physiol 264:995–1002
10.
go back to reference Kanematsu M, Osada S, Amaoka N, et al. (2004) Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with angiographically assisted CT. AJR 183:1585–1593PubMed Kanematsu M, Osada S, Amaoka N, et al. (2004) Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with angiographically assisted CT. AJR 183:1585–1593PubMed
11.
go back to reference Kanematsu M, Osada S, Amaoka N, et al. (2005) Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver and correlation with MRI findings. AJR 184:832–841PubMed Kanematsu M, Osada S, Amaoka N, et al. (2005) Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver and correlation with MRI findings. AJR 184:832–841PubMed
12.
go back to reference Yamaguchi R, Yano H, Nakashima Y, et al. (2000) Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rep 7:725–729PubMed Yamaguchi R, Yano H, Nakashima Y, et al. (2000) Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rep 7:725–729PubMed
13.
go back to reference Kwak BK, Shim HJ, Park ES, et al. (2001) Hepatocellular carcinoma: correlation between vascular endothelial growth factor level and degree of enhancement by multiphase contrast-enhanced computed tomography. Invest Radiol 36:487–492PubMed Kwak BK, Shim HJ, Park ES, et al. (2001) Hepatocellular carcinoma: correlation between vascular endothelial growth factor level and degree of enhancement by multiphase contrast-enhanced computed tomography. Invest Radiol 36:487–492PubMed
14.
go back to reference Jeng KS, Sheen IS, Wang YC, et al. (2004) Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection? World J Gastroenterol 10:676–681PubMed Jeng KS, Sheen IS, Wang YC, et al. (2004) Is the vascular endothelial growth factor messenger RNA expression in resectable hepatocellular carcinoma of prognostic value after resection? World J Gastroenterol 10:676–681PubMed
15.
go back to reference Ng IO, Poon RT, Lee JM, et al. (2001) Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol 116:838–845PubMed Ng IO, Poon RT, Lee JM, et al. (2001) Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol 116:838–845PubMed
16.
go back to reference Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845PubMedCrossRef Shweiki D, Itin A, Soffer D, Keshet E (1992) Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843–845PubMedCrossRef
17.
go back to reference Mukhopadhyay D, Tsiokas L, Zhou XM, et al. (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375:577–581PubMedCrossRef Mukhopadhyay D, Tsiokas L, Zhou XM, et al. (1995) Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375:577–581PubMedCrossRef
18.
go back to reference von Marschall Z, Cramer T, Hocker M, et al. (2001) Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut 48:87–96 von Marschall Z, Cramer T, Hocker M, et al. (2001) Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. Gut 48:87–96
19.
go back to reference Ishikawa K, Mochida S, Mashiba S, et al. (1999) Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem Biophys Res Commun 254:587–593PubMed Ishikawa K, Mochida S, Mashiba S, et al. (1999) Expressions of vascular endothelial growth factor in nonparenchymal as well as parenchymal cells in rat liver after necrosis. Biochem Biophys Res Commun 254:587–593PubMed
20.
go back to reference Matsui O, Kadoya M, Kameyama T, et al. (1991) Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 178:493–497PubMed Matsui O, Kadoya M, Kameyama T, et al. (1991) Benign and malignant nodules in cirrhotic livers: distinction based on blood supply. Radiology 178:493–497PubMed
21.
go back to reference Blancher C, Moore JW, Talks KL, et al. (2000) Relationship of hypoxiainducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 60:7106–7113PubMed Blancher C, Moore JW, Talks KL, et al. (2000) Relationship of hypoxiainducible factor (HIF)-1alpha and HIF-2alpha expression to vascular endothelial growth factor induction and hypoxia survival in human breast cancer cell lines. Cancer Res 60:7106–7113PubMed
22.
go back to reference Yoshikawa J, Matsui O, Takashima T, et al. (1988) Fatty metamorphosis in hepatocellular carcinoma: radiologic features in 10 cases. AJR 151:717–720PubMed Yoshikawa J, Matsui O, Takashima T, et al. (1988) Fatty metamorphosis in hepatocellular carcinoma: radiologic features in 10 cases. AJR 151:717–720PubMed
23.
go back to reference Kutami R, Nakashima Y, Nakashima O, et al. (2000) Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33:282–289PubMedCrossRef Kutami R, Nakashima Y, Nakashima O, et al. (2000) Pathomorphologic study on the mechanism of fatty change in small hepatocellular carcinoma of humans. J Hepatol 33:282–289PubMedCrossRef
24.
go back to reference Scarfo LM, Weller PF, Farber HW (2001) Induction of endothelial cell cytoplasmic lipid bodies during hypoxia. Am J Physiol Heart Circ Physiol 280:294–301 Scarfo LM, Weller PF, Farber HW (2001) Induction of endothelial cell cytoplasmic lipid bodies during hypoxia. Am J Physiol Heart Circ Physiol 280:294–301
25.
go back to reference Rosmorduc O, Wendum D, Corpechot C, et al. (1999) Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 155:1065–1073PubMed Rosmorduc O, Wendum D, Corpechot C, et al. (1999) Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol 155:1065–1073PubMed
26.
go back to reference El-Assal ON, Yamanoi A, Soda Y, et al. (1998) Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27:1554–1562PubMedCrossRef El-Assal ON, Yamanoi A, Soda Y, et al. (1998) Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27:1554–1562PubMedCrossRef
27.
go back to reference Suzuki K, Hayashi N, Miyamoto Y, et al. (1996) Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56:3004–3009PubMed Suzuki K, Hayashi N, Miyamoto Y, et al. (1996) Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56:3004–3009PubMed
Metadata
Title
Expression of vascular endothelial growth factor in hepatocellular carcinoma and the surrounding liver: correlation with MR imaging and angiographically assisted CT
Authors
M. Kanematsu
S. Osada
N. Amaoka
S. Goshima
H. Kondo
N. Moriyama
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Abdominal Radiology / Issue 1/2006
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-005-0091-4

Other articles of this Issue 1/2006

Abdominal Radiology 1/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine